药易购
(300937)
| 流通市值：18.26亿 | | | 总市值：27.89亿 |
| 流通股本：6264.79万 | | | 总股本：9566.67万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,235,469,610.27 | 2,225,319,754.46 | 1,237,408,296.37 | 4,430,412,450.51 |
| 营业收入 | 3,235,469,610.27 | 2,225,319,754.46 | 1,237,408,296.37 | 4,430,412,450.51 |
| 二、营业总成本 | 3,211,095,776.4 | 2,201,464,225.02 | 1,215,251,341.39 | 4,344,720,824.45 |
| 营业成本 | 2,956,968,916.08 | 2,039,797,580.23 | 1,136,598,621.14 | 4,062,812,564.02 |
| 税金及附加 | 5,808,090.97 | 3,792,390.96 | 1,878,781.2 | 7,500,955.81 |
| 销售费用 | 180,912,080.87 | 112,209,368.32 | 53,858,024.16 | 190,621,758.5 |
| 管理费用 | 48,263,363.14 | 32,240,316.64 | 16,035,880.23 | 57,472,198.28 |
| 研发费用 | 12,565,314.67 | 9,322,429.66 | 4,797,456.92 | 19,320,715.88 |
| 财务费用 | 6,578,010.67 | 4,102,139.21 | 2,082,577.74 | 6,992,631.96 |
| 其中:利息费用 | 7,392,613.53 | 5,082,217.33 | 2,496,778.82 | 6,582,689.83 |
| 其中:利息收入 | 3,182,109.29 | 2,486,590.36 | 1,084,694.81 | 2,268,446.49 |
| 加:投资收益 | -468,072.44 | -394,329.92 | -20,452.37 | 1,540,241.15 |
| 资产处置收益 | -496,970.1 | -598,652.61 | -31,613.64 | -52,690.45 |
| 资产减值损失(新) | 816,311.42 | 684,534.6 | 636,781.83 | -9,093,615.87 |
| 信用减值损失(新) | -15,381,890.49 | -16,141,199.06 | -17,055,956.13 | -13,159,533.04 |
| 其他收益 | 1,391,409.14 | 1,118,871.15 | 761,647.73 | 3,672,019.48 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 10,234,621.4 | 8,524,753.6 | 6,447,362.4 | 68,598,047.33 |
| 加:营业外收入 | 917,395.36 | 801,529.23 | 65,888.42 | 1,655,279.73 |
| 减:营业外支出 | 770,923.93 | 494,303.74 | 110,265.68 | 371,454.25 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 10,381,092.83 | 8,831,979.09 | 6,402,985.14 | 69,881,872.81 |
| 减:所得税费用 | -92,078.43 | -1,159,398.97 | -791,181.36 | 13,108,246.39 |
| 六、净利润 | 10,473,171.26 | 9,991,378.06 | 7,194,166.5 | 56,773,626.42 |
| 持续经营净利润 | 10,473,171.26 | 9,991,378.06 | 7,194,166.5 | 56,773,626.42 |
| 归属于母公司股东的净利润 | 13,931,460.39 | 12,095,746.45 | 9,225,531.31 | 59,532,026.96 |
| 少数股东损益 | -3,458,289.13 | -2,104,368.39 | -2,031,364.81 | -2,758,400.54 |
| (一)基本每股收益 | 0.15 | 0.13 | 0.1 | 0.62 |
| (二)稀释每股收益 | 0.15 | 0.13 | 0.1 | 0.62 |
| 八、其他综合收益 | - | - | - | 1,497,000 |
| 归属于母公司股东的其他综合收益 | - | - | - | 1,497,000 |
| 九、综合收益总额 | 10,473,171.26 | 9,991,378.06 | 7,194,166.5 | 58,270,626.42 |
| 归属于母公司股东的综合收益总额 | 13,931,460.39 | 12,095,746.45 | 9,225,531.31 | 61,029,026.96 |
| 归属于少数股东的综合收益总额 | -3,458,289.13 | -2,104,368.39 | -2,031,364.81 | -2,758,400.54 |
| 公告日期 | 2024-10-25 | 2024-08-28 | 2024-04-25 | 2024-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |